Washington ExaminerLean R·
Pancreatic cancer had a 13% survival rate. Trump’s FDA just changed everything
The Food and Drug Administration’s approval of an important new drug for patients with advanced pancreatic cancer represents not only a groundbreaking scientific and medical development but also a critical step forward in the Trump administration’s efforts to speed the development of innovative treatment options that can make a meaningful difference in the lives of […]
Read at Washington Examiner →
